Indication
Progressive Oligodendroglioma
1 clinical trial
4 products
Clinical trial
ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult PatientsStatus: Not yet recruiting, Estimated PCD: 2027-12-01
Product
TTRNA-DC vaccinesProduct
TTRNA-xALTProduct
Td vaccine